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Abstract
Background: Autism spectrum disorders (ASDs) represent a heterogeneous group of disorders with a wide range
of behavioral impairments including social and communication deficits. Apart from these core symptoms, a
significant number of ASD individuals display higher levels of anxiety, and some studies indicate that a subset of
ASD individuals have a reduced ability to be fear conditioned. Deciphering the molecular basis of ASD has been
considerably challenging and it currently remains poorly understood. In this study we examined the molecular basis
of autism-like impairments in an environmentally induced animal model of ASD, where pregnant rats are exposed
to the known teratogen, valproic acid (VPA), on day 12.5 of gestation and the subsequent progeny exhibit ASD-like
symptoms. We focused our analysis on the basal and lateral nucleus of the amygdala (BLA), a region of the brain
found to be associated with ASD pathology.
Methods: We performed whole genome gene expression analysis on the BLA using DNA microarrays to examine
differences in gene expression within the amygdala of VPA-exposed animals. We validated one VPA-dysregulated
candidate gene (Homer1a) using both quantitative PCR (qRT-PCR) and western blot. Finally, we overexpressed
Homer1a within the basal and lateral amygdala of naïve animals utilizing adeno-associated viruses (AAV) and
subsequently examined these animals in a battery of behavioral tests associated with ASD, including auditory fear
conditioning, social interaction and open field.
Results: Our microarray data indicated that Homer1a was one of the genes which exhibited a significant
upregulation within the amygdala. We observed an increase in Homer1a messenger RNA (mRNA) and protein in
multiple cohorts of VPA-exposed animals indicating that dysregulation of Homer1a levels might underlie some of
the symptoms exhibited by VPA-exposed animals. To test this hypothesis, we overexpressed Homer1a within BLA
neurons utilizing a viral-mediated approach and found that overexpression of Homer1a impaired auditory fear
conditioning and reduced social interaction, while having no influence on open-field behavior.
Conclusions: This study indicates that dysregulation of amygdala Homer1a might contribute to some autism-like
symptoms induced by VPA exposure. These findings are interesting in part because Homer1a influences the
functioning of Shank3, metabotropic glutamate receptors (mGluR5), and Homer1, and these proteins have
previously been associated with ASD, indicating that these differing models of ASD may have a similar molecular
basis.
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Background
Autism spectrum disorders (ASD) represent an etiologic-
ally heterogeneous group of disorders that are believed to
be caused by a myriad of genetic and environmental fac-
tors. ASD patients typically exhibit symptoms of repetitive
behavior, impaired social interactions and deficits in social
communication. These patients also frequently exhibit
intellectual disability, epilepsy, attention deficit hypera-
ctivity disorder (ADHD), sleep disturbances [1–3], and
anxiety [4, 5]. Additionally, some ASD patients may
exhibit a reduced ability to be fear conditioned [6].
It is difficult to trace the pathology of a heterogeneous
disorder such as ASD to a single brain region. However,
the presence of significant social and emotional abnormal-
ities among the human ASD population indicates atypical
amygdala function including the basolateral complex
which plays an important role in processing emotional
and social cues [7–13]. Collectively, more research is
needed to further elucidate the underlying molecular and
cellular basis of amygdala dysfunction in ASD.
Twin and family studies have indicated that there is a
strong genetic basis for ASD [14–18]. The genetics of
ASD is highly complex, involving multiple genes with a
high degree of genetic variation [19, 20]. Notably, a
recent study found that siblings with ASD often possess
very different genomic mutations, indicating that even
within a single family, the cause of ASD can be hetero-
geneous [21]. Although the genetic basis of ASD is well
documented, the recent increase in clinical cases of
idiopathic ASD indicates that environmental risk factors
might also have an important contribution, either by
causing new mutations or by increasing the risk for ASD
in a genetically predisposed individual [22–24].
Studies utilizing animal models of ASD have signifi-
cantly increased over the past decade, allowing researchers
to gain a better understanding of the neurobiology of
ASD. One such animal model is the valproic acid (VPA)
model of autism [25–27]. This model is based on the
discovery that administration of the anticonvulsant drug
VPA during the first trimester of pregnancy increases the
likelihood of having children with ASD and intellectual
disability [22–24, 28, 29]. In this animal model, pregnant
dams are administered a single dose of VPA on or around
embryonic day 12.5 of gestation, during the time of neural
tube closure. The resultant progeny display anatomical
and behavioral abnormalities similar to human ASD
[26, 30–32], including deficits in social interaction,
increased levels of anxiety, and abnormal fear learning
[33–36]. Several independent groups have speculated
that synaptic deficits may contribute an important role
in the causal mechanism of ASD. Synaptic abnormal-
ities have been observed in fragile X [37, 38], Rett
syndrome [39], Angelman syndrome [40], and tuberous
sclerosis complex [41–43]. Proteins required for normal
synaptic functioning have also been implicated in ASD
such as Shank, MeCP2, Reelin, and Neuroligin. [43–47].
These proteins contribute an important role to synaptic
plasticity and learning and memory.
In the current study, we aimed to understand the
molecular basis of amygdala dysfunction, in animals
exposed to VPA in utero. We performed genome-wide
gene expression profiling on amygdala tissue obtained
from adult rats that were exposed to VPA in utero. We
identified Homer1a, which is a dominant negative regu-
lator of the critical synaptic scaffolding protein Homer1,
to be significantly upregulated in the basal and lateral
amygdala (BLA) of VPA-exposed animals. Homer1a is
especially interesting since it interacts directly with
important synaptic proteins such as metabotropic glutam-
ate receptors (mGluR5) and Shank, which have previously
been associated with ASD [48–54]. Additionally, Homer1a
contributes a critical role in plasticity and fear learning
[55–58] indicating that its dysregulation could underlie
fear learning abnormalities observed in VPA-exposed ani-
mals. Therefore, we hypothesized that overexpression of
Homer1a in the BLA could impair amygdala-dependent
phenomena such as fear learning or social interaction
behavior [11, 59–63]. To test our hypothesis, we used a
viral-mediated approach and overexpressed Homer1a in
the BLA of naive animals. We found that overexpression
of Homer1a in the BLA impaired fear learning and
reduced social interaction in the animals but had no influ-
ence on locomotor behavior or anxiety as measured by
the open-field test. Our findings are intriguing in part
because the Homer1 gene has been previously associated
with the human ASD population [64] thus underscoring
that an environmentally induced animal model of ASD
could provide novel avenues for elucidating the neurobio-




To obtain progeny exposed to either VPA or saline in
utero, rats were mated overnight and pregnancy was
determined by the presence of a vaginal plug (E1). Dams
were given a single intraperitoneal injection of 600 mg/
kg of VPA in 0.9 % saline or saline alone (control) on
day E12.5 of pregnancy as previously described [30, 65].
All dams were housed individually and left undisturbed
until they gave birth. The offspring were weaned on
postnatal day (PD) 21, and animals of either sex were
housed separately. A total of 13 saline litters and 19
VPA litters from 4 different cohorts were used for the
molecular experiments. Animals exposed to VPA/saline
were sacrificed for molecular experiments at approxi-
mately PD 90, and these animals were sacrificed in a
counterbalanced fashion across the groups. Naïve adult
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male Sprague Dawley rats (Harlan) weighing 300–400 g
were used for the experiments where adeno-associated
viruses (AAV) were infused into the BLA. All animals
were housed individually and maintained on a 12 h
light/dark cycle. Food and water were provided ad libi-
tum throughout the experiments. Animal use procedures
were in accordance with the National Institutes of
Health Guide for the Care and Use of Laboratory
Animals and were approved by the University of Texas
at Dallas Animal Care and Use Committee.
DNA microarray and analysis
Animals were lightly sedated by exposing them to CO2
for ~1 min, followed by immediate decapitation; the
brains were rapidly dissected and immediately frozen
with powdered dry ice and stored at −80 °C until further
processing. Unilateral amygdala punches were obtained
with a 1-mm punch tool (Fine Science Tools), and total
RNA was isolated using RNAqueous Micro kit (Ambion).
The resultant RNA was purified via precipitation using
Pellet Paint NF (Novagen) to remove potential inhibitors
of reverse transcription followed by RNA amplification
and biotin labeling using the MessageAmp II-Biotin En-
hanced Single Round cRNA Amplification Kit (Ambion).
DNA microarray hybridization was performed at the
University of Texas at Southwestern Medical Center
Genomics and Microarray Core Facility. Eight cRNA
samples (n = 4 for VPA, n = 4 for saline) were hybridized
to Affymetrix GeneChip Rat Genome 230 2.0 Arrays con-
taining 31,000 probes for genome scale gene expression
analysis. Gene lists were created based on the criteria that
the gene must exhibit an average fold difference of 1.5-
fold or greater in pairwise comparisons between VPA and
saline amygdala samples with a non-corrected, t test p
value of p < 0.05. The MAQC Consortium has reported
that this approach can be successful in identifying repro-
ducible gene lists [66].
Laser microdissection, RNA purification, cDNA synthesis,
and qRT-PCR
Laser microdissection of basal and lateral amygdala
(BLA) followed by RNA purification, complementary
DNA (cDNA) synthesis and quantitative PCR (qRT-
PCR) were performed as described previously [67].
Briefly, hemisected 8–10 μm coronal sections containing
the amygdala (−2.3 to −3.3 mm with respect to bregma)
were mounted on MMI laser microdissection (LMD)
slides (product #50102). Prior to LMD, the slides were
dehydrated and the BLA nuclei were laser microdis-
sected using a SmartCut Laser Microdissection System
configured on an Olympus CKX41 inverted microscope.
Each microdissected BLA/slice was deposited in 25 μL
of cell lysis buffer (RNAqueous-Micro Kit; Ambion).
This was repeated for ~6–7 slices per animal per side,
and the resultant 25 μl aliquots were frozen at −80 °C
until further processing. The samples were thawed and
pooled, and the RNA was isolated according the manufac-
turer’s instructions using the RNAqueous-Micro Kit. The
resultant RNA was purified via precipitation using Pellet
Paint NF (Novagen). RNA was converted to cDNA for
each sample in a 20 μL reaction using 250 nM of oligodT
(Invitrogen), 1 μL reverse transcriptase (Invitrogen), and
1 μL SUPERase In (Ambion). The cDNA was purified
using Pellet Paint NF (Novagen) and re-suspended in
100 μL of nuclease free water. One microliter of cDNA
was used per 20 μL Taqman PCR assay (Applied Biosys-
tems). One microliter of a 20X Taqman custom Primer/
Probe for Homer1a or Homer1 (Rn00581785_m1 FAM)
(Invitrogen) was used per reaction. The primer sequence
for Homer 1a is FP 5′-CTGCTCCAAAGGAAAGCCT
TGC-3′ and RP 5′-AAACAACCTTCAATGCTGACGG-
3′. The probe sequence is 5′-[FAM] CGTCCTCTGTG
GCACCTCTGTGGGC [TAMRA]-3′ [68]. Samples were
prepared and loaded into a 96-well plate in triplicate and
relative gene concentrations were normalized and quanti-
tated against glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) (Rn01775763_g1 VIC; Invitrogen), levels using
CFX96 real-time PCR system (BioRad) using the standard
cycling parameters specified by Applied Biosystems. The
data were analyzed using a two-tailed t test. Differences
were considered significant if p < 0.05. For the most accur-
ate representation of qRT-PCR experimental data vari-
ance, all qRT-PCR data are represented as the average
threshold cycle (Ct) difference values for each group after
normalization to GAPDH, with the error bars repre-
senting the standard error of the mean for each
group. Average fold change values result from the
transformation of the raw qRT-PCR data using the
equation: 2(average Ct difference value) = average fold change.
AAV production, purification, and titering
AAV2 genome plasmids which are designed to express
either Homer1a or GFP were generously provided by Dr.
Matthias Klugmann [69]. Specifically, the expression
cassettes contain a 1.1-kb CBA promoter composed of
266 bp of the cytomegalovirus immediate early enhancer
and 410 bp sequence containing exon 1 of CBA, a
hybrid CBA/rabbit β-globin intron and the 5′ end of a
β-globin exon which control the expression of an HA-
tagged Homer1a transgene or eGFP transgene [70]. The
AAV2 viral plasmids used for the second set of viral
experiments were generously provided by Dr. Martin
Schwarz [58]. They are designed to express either venus
tagged Homer1a (H1aV) or a similar control venus
tagged Homer1a mutant (H1aV(W24A)) containing a
point mutation (W24A) in the EVH1 domain of H1aV,
which abolishes the ability of Homer1a to interact with
postsynaptic protein partners. These plasmids have an
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AAV backbone containing the 480 bp human synapsin
core promoter. All viral plasmids within this study con-
tain a woodchuck posttranscriptional regulatory element
(WPRE) and the bovine growth hormone polyA se-
quence. AAV viruses used within this study were pseu-
dotyped to create AAV2/DJ8 viruses, and these were
produced and purified using a triple transfection method
in 293FT cells and purified on an iodixanol step gradient
as described previously [71]. Viral titers were determined
using a quantitative-PCR-based titering method using a
CFX96 real-time PCR system (Bio-Rad) using the stand-
ard cycling parameters specified by Applied Biosystems
with custom Taqman primer/probes directed to the
WPRE sequence within the viral genome. The primer
sequences for WPRE are FP 5′-CCGTTGTCAGGC
AACGTG-3′ and RP 5′-AGCTGACAGGTGGTGGC
AAT-3′. The WPRE probe sequence was 5′-[FAM]-T
GCTGACGCAACCCCCACTGGT-[TAMRA]-3′. Final
viral titers were computed based on a standard curve
and reported as genome copies (GC/ml) as previously
described [71].
AAV infusions
Twenty-eight gauge custom-made infusion cannula
(C315G, Plastics One) were inserted into polyethylene
tubing (I.D. 0.015 in., O.D. 0.043 in., wall thickness
0.0140 in.) (A-M systems, Inc.) which were ~20 in. long,
and then, these lines were backfilled with sesame oil and
attached to 2 μL, 23-gauge (88500) stainless steel
Hamilton syringes (Hamilton Company). Under a mix-
ture of ketamine (100 mg/kg) and xylazine (10.0 mg/kg)
anesthesia, rats were stereotaxically implanted bilaterally
with the 28-gauge infusion cannula (described above)
targeting the BLA [AP −2.9, ML ±5.0, DV −8.6]. Viruses
were bilaterally infused for 15 min at a rate of 0.09 uL/
min. A total of 1 uL of virus consisting of a viral titer of
~1.5E13 GC/mL was infused per side. For animals that
received the HA-Homer1a virus, the HA-Homer1a virus
was mixed with a very small amount of the GFP control
virus (6.5E8 viral particles) and then infused. This was to
allow for visualization of the viral transduction within
the BLA, to confirm the virus was indeed correctly
placed and virus was successfully infused into the BLA.
The total number of viral particles was kept constant be-
tween both of the GFP control group and the HA-
Homer1A group. Following infusions, the infusers were
left in for ten additional minutes to allow diffusion of
the virus away from the cannula after which they were
withdrawn, and the incision was closed using 9 mm
wound clips (Mikron Precision, Inc.). The animals were
allowed to heal for a week, and the wound clips were re-
moved after a week using a wound clip remover (Auto-
clip, Mikron Precision, Inc). Three weeks post infusion,
the animals were tested on a battery of behavioral tests.
Each behaviorally tested animal was handled for 2 days
prior to behavior tests. After the completion of behav-
ioral tests, the rats were sacrificed in a counterbalanced
fashion across the groups by anesthetizing with an
overdose of chloral hydrate (250 mg/kg) and perfused
with phosphate buffered saline (1X phosphate buffer,
150 mM NaCl) and 10 % buffered formalin. The brains
were fixed in 10 % formalin for 4–5 h followed by
cryoprotection in 30 % sucrose in 1X PBS. Only animals
which possessed correctly placed viral transduction for
each experiment were included in the analysis.
Western blot
Rats were decapitated after sedation in CO2, and
brains were frozen at −80 °C until further processing.
Punches containing the BLA were obtained with a 1-
mm punch tool (Fine Science Tools) from 200-μm-
thick sections taken on a cryostat. Punches were
manually dounced homogenized in 200 μL of ice-cold
lysis buffer [10 mM Tris-HCl, pH 7.5, 1 mM EDTA,
2.5 mM sodium pyrophosphate, 1 % NP-40, 0.5 %
sodium deoxycholate, 1 % SDS, 1 mM DTT, protease
inhibitor cocktail (Roche)]. Protein concentrations
were assessed and normalized across homogenates
using a BCA kit (Thermo scientific). Sample buffer
was added to the homogenates, and the samples were
boiled for 5 min. Homogenates were electrophoresed
on 5–15 % Tris-HCl gels (Bio-rad) and transferred
overnight to Immobilon-P (Millipore) at 4 °C.
Western blots were blocked in TTBS buffer (50 mM
Tris-HCl, pH 7.5, 150 mM NaCl, and 0.05 % Tween
20) with 5 % nonfat dry milk (American Bioanalytical)
for 1 h and then incubated with the following
primary antibodies: Homer1a antibody (1:1000; cat #
160013, Synaptic Systems), anti-HA antibody (1:1000;
cat# MMS-101P, Covance), and anti-GAPDH (1:5000;
cat# ab9483, Abcam) overnight at 4 °C on a shaker.
Blots were then incubated with anti-rabbit or anti-mouse
antibodies conjugated to horseradish peroxidase (Cell
Signaling) for 1 h at room temperature and developed
using West Pico chemiluminescent substrate (Pierce
Laboratories). Densitometry was conducted using NIH
ImageJ software. To control for inconsistencies in
loading, optical densities were normalized to GAPDH
proteins.
Auditory fear conditioning
Animals were fear conditioned 21 days post viral
infusion. A Coulbourn Instruments fear conditioning
system with computer-controlled shockers, USB cameras
for video monitoring/video capture, and FreezeFrame
Software (Actimetrics) for unbiased behavioral analysis
was used to auditory fear condition rats and to test for
conditioned fear responses.
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Training
Rats were auditory fear conditioned with a single
trial consisting of a 180-s acclimation period (pre-
shock period) followed by the presentation of a 30-s,
5-kHz, 75-dB tone that co-terminated with a 1-s,
1.5-mA foot shock. Animals remained in the training
chamber for an additional minute following the de-
livery of the foot shock, and subsequently, the ani-
mals were placed back into their home cages.
STM
Animals were tested for retention of Short-term
memory (STM) 3 h post fear conditioning in a novel
context which had distinct tactile, olfactory, and vis-
ual cues compared to the auditory fear conditioning
training chamber. STM testing consisted of a 1-min
acclimation period followed by the presentation of
(30 s, 5 kHz, 75 dB) tones with an inter-trial interval
of 2 min. Following the last tone, animals remained
in the box for an additional 1 min and were subse-
quently returned to their home cages.
LTM
Animals were tested for long-term memory (LTM)
24 h post auditory fear training in the same manner
as STM was. All trials were recorded using Freeze
frame software. The absence of any movement ex-
cluding respiration was recorded as a freezing re-
sponse, which was calculated by the automated
Freeze frame software.
Anxiety/locomotory behavior
General anxiety/innate fear and locomotor behavior
were examined in an open field. The open-field ap-
paratus consisted of a wooden square (1.2 m × 1.2 m)
box. The periphery of the box was designated as the
outer 0.30 m region of the box, and the center zone
was designated the 0.6 m × 0.6 m square region at the
center of the box. Each animal was placed in a corner
of the box and allowed to freely explore the field for
10 min in low light (~100 lux) while being video re-
corded using a USB camera. After the session, the
animal was removed from the apparatus and returned
to the home cage and the open-field apparatus was
cleaned with 10 % ethanol and allowed to dry com-
pletely between trials. Total entries to the center of
the open field, total time spent at the center, total
distance traveled, and mean speed for each animal
were calculated by the automated behavioral tracking
system, ANYmaze (Stoelting). The total distance trav-
eled for each animal was used to compare overall
locomotory behavior between the groups. Differences
in open-field center time between the groups were
used to determine if there were differences in anx-
iety/innate fear.
Social interaction test
Social interaction between rats was measured using a
protocol similar to one described previously [65]. On
day 1, the subject rat (Homer1a or control animal) was
habituated to the empty social interaction apparatus
(61 cm × 61 cm gray box) for 5 min. On day 2, a wired
enclosure was placed in the corner of the social inter-
action box and a novel test rat which had no previous
exposure to the subject rat was placed inside this enclos-
ure. The subject rat was then introduced into the social
interaction box and allowed to interact with the novel
test rat for 10 min. The presence of the test rat in the
wired enclosure allowed the measurement of social
behavior initiated by the subject rat only. The region
surrounding the novel test rat chamber was marked as
the social interaction zone, (5-cm-wide region surround-
ing the outside of the wired enclosure). The social inter-
action apparatus was wiped down with 10 % ethanol
between animals to remove olfactory cues from previous
trials. The amount of time spent in the social interaction
zone, sniffing, and exploring the test rat was recorded by
automated ANYmaze software and considered as a
measure of social interaction behavior. Mean distance
traveled in the apparatus measured the overall locomo-
tory behavior of the animals.
Statistical analysis
All statistics were performed using SPSS 12.0 or Stat-
View. Results were expressed as mean ± SEM in the text
and figures. Data were analyzed for normality using
Shapiro-Wilk test. Nonparametric statistical tests were
used in experiments with small sample sizes (n < 10) [72,
73]. Equivalent parametric tests for the same were also
performed and reported (Additional file 1). Within
group, comparisons for repeated measure were per-
formed using Friedman tests followed by Mann-
Whitney U tests for between group comparisons as
described previously [74]. A Student’s t test was used
to compare means between groups where appropriate.
A paired Student’s t test was used to compare means
within group. Differences with p < 0.05 were consid-
ered statistically significant.
Results
In utero VPA exposure dysregulates gene expression
within the adult rat amygdala
To determine if exposure to VPA in utero influences
gene expression in the BLA, we performed whole
genome, gene expression profiling using Affymetrix
DNA microarray gene chips. Total RNA was purified
from BLA tissue (saline = 4, VPA = 4) and subjected
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to RNA amplification and biotin labeling followed by
genome microarray hybridization and analysis. A
total of 59 genes were differentially expressed (>1.5-
fold change; p < 0.05) in the BLA of VPA-exposed
animals compared to saline animals (Additional file
2). Interestingly, 14 of the 59 genes identified by the
microarray screen (i.e., 23.7 %) have been previously
associated with human ASD and these genes are
listed in Fig. 1a. Homer1a was identified as one of
the genes significantly upregulated in the BLA of
VPA-exposed animals. Two independent probe sets
(Probe Set ID: 1370997_at, 1370454_at) on the DNA
microarray indicated that Homer1a was upregulated.
Because Homer1a partakes in mGluR5 signaling and
regulates interactions of long forms of Homer1 with
Shank, and all three of these proteins have been pre-
viously associated with ASD, we focused our atten-
tion on Homer1a. To begin our validation to
determine if Homer1a is indeed upregulated within
the amygdala due to VPA exposure, we performed
qRT-PCR on the amplified RNA (aRNA) samples
used for DNA microarray analysis. An average Ct
(cycle threshold) difference of 1.14 ± 0.2 was found
between the VPA- and saline-exposed groups, which
corresponds to a 2.2 average fold upregulation [t(7) = 2.82,
p = 0.02] of Homer1a messenger RNA (mRNA) in VPA
animals, and these values are consistent with the micro-
array data (Fig. 1b).
Homer1a mRNA and protein are upregulated within the
adult BLA from VPA-exposed animals
DNA microarray data can be prone to error, due to
technical and biological variability, and therefore,
there is a risk of identifying genes that are false posi-
tives using this technology. Therefore, to circumvent
this potential issue, we examined Homer1a expression
in an independent cohort of animals exposed to VPA
or saline. Adult animals that had been exposed to
VPA or saline, in utero, were sacrificed, the BLA was
laser microdissected, and qRT-PCR was performed on
RNA extracted from this tissue (Fig. 2a). Significant
upregulation of Homer1a mRNA was observed as re-
vealed by the average Ct difference of 0.88 ± 0.19
which corresponds to 1.85-fold increase [t(18) = 4.09,
p = 0.006, saline = 10, VPA = 10] in Homer1a mRNA
levels in VPA animals compared to saline animals
(Fig. 2b). Homer1a is produced by the conversion of
an intronic to exonic sequence in a transcript that
normally would code for the long forms of Homer1
[75]. Therefore, we next examined if total levels of
Homer1 transcripts (i.e., all isoforms of Homer1) were
dysregulated within the BLA due to VPA exposure.
To do this, we repeated the qRT-PCR, with PCR
primers that detect all Homer1 transcripts. However,
there was no difference in the total Homer1 mRNA
levels [t(14) = −0.69, p = 0.49, saline = 9, VPA = 7] in
VPA-exposed animals compared to saline animals
(Fig. 2c). Next, we examined if Homer1a protein
levels were increased within the BLA following VPA
exposure. Adult VPA- and saline-exposed animals
were sacrificed, the BLA was microdissected, and pro-
tein from this tissue was examined by western blot.
This experiment revealed a significant upregulation of
Homer1a protein [t(30) = −2.26, p = 0.04, saline = 16,
VPA = 16] in the BLA of VPA compared to saline-
exposed animals (Fig. 2d). Collectively, these data
Fig. 1 Whole genome microarray indicates Homer1a is upregulated in the BLA of VPA-exposed animals. a The table depicts the list of
genes dysregulated in the basolateral amygdala (BLA) of VPA-exposed animals compared to saline-exposed animals, which also have been previously
associated with ASD (p < 0.05) [64, 110–122]. b Upregulation of Homer1a was validated using qRT-PCR with Homer1a-specific probes using the same
aRNA samples that were examined via DNA microarray. Bars represent the mean ± standard error of the mean (SEM) (*p < 0.05)
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indicate that Homer1a is upregulated at both mRNA
and protein levels across various cohorts of VPA-
exposed animals.
Viral-mediated overexpression of Homer1a in the BLA
impaired social interaction but did not affect innate fear
and locomotory behavior
Disrupted social behaviors and increased innate fear are
prominent symptoms of a number of psychiatric disorders
including autism. We and others have shown that animals
exposed to VPA in utero have higher levels of anxiety and
reduced social interaction, similar to symptoms observed
in ASD. Since the BLA contributes an important role in
modulating innate fear [13, 76], as well as social behavior
[60, 77], we wanted to determine if increased expression
of Homer1a within BLA neurons can induce autistic-like
symptoms such as impaired social interaction and in-
creased innate fear. AAV viruses designed to express an
HA-tagged Homer1a transgene or GFP transgene (Fig. 3a)
were stereotaxically injected into the BLA of naïve ani-
mals. Twenty-one days post infusion, the animals were
sacrificed, the BLA was microdissected, and total protein
homogenates were examined via western blotting to
confirm the presence of the HA-tagged Homer1a. The
HA-tagged Homer1a was visible as a band slightly larger
than the endogenous Homer1a (Fig. 3c). A similar sized
band was not detected in the samples that received the
GFP virus, as expected. GFP expression of virus was
confirmed by examining tissue slices that contained BLA
transduced with the AAV-GFP virus using fluorescence
microscopy (Fig. 3b). Next, another set of animals were
bilaterally infused into the BLA with AAV-Homer1a and
AAV-GFP viruses, and 21 days later, the animals under-
went a battery of behavioral tests (Fig. 3d). First, the ani-
mals were examined in an open field to measure
potential changes in locomotor behavior and innate
fear. Mann-Whitney U test revealed no significant
difference between the Homer1a and GFP animals in the
number of center entries (p = 0.66) and center time spent
(p = 0.66) (Fig. 4a, b) suggesting overexpression of
Homer1a in the BLA did not influence innate fear in
this open field task. Additionally, the mean distance
traveled (p = 0.99) (GFP = 7, Homer1a = 6) by the
Homer1a and GFP animals in the open field
Fig. 2 Upregulation of BLA Homer1a mRNA in a different cohort of VPA-exposed animals. a Representative picture of before (i) and after (ii) laser
microdissection of the BLA tissue. b qRT-PCR for Homer1a revealed an upregulation of Homer1a mRNA in an independent cohort of VPA-exposed
animals compared to saline-exposed animals. c qRT-PCR for Homer1, which can identify all isoforms of Homer, did not reveal an overall upregulation of
Homer1 in VPA-exposed animals compared to saline animals. d Western blot depicting upregulation of Homer1a (~27 kDa) in VPA-exposed animals
compared to saline controls. Bars represent the mean ± standard error of the mean (SEM) (*p < 0.05)
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apparatus were similar (Fig. 4c) indicating that overall
locomotory behavior remains unaffected by overex-
pression of Homer1a in the BLA.
Next, we examined how overexpression of Homer1a
within the BLA influences social interaction behavior in an-
other group of animals. Animals received AAV-Homer1a
or AAV-GFP as described above and 21 days following viral
infusion; the social interaction behavior of these animals
was examined within a social interaction apparatus with a
novel test rat. We observed that the amount of time spent
by the AAV-Homer1a animals with the novel rat was
significantly less compared to the amount of time the AAV-
GFP animals spent with the novel rat (p = 0.04; Mann-
Whitney U test) (GFP = 8, Homer1a = 9) (Fig. 4d). The
Homer1a and GFP animals exhibited similar mean distance
traveled values, which indicated that within the social inter-
action apparatus, these groups did not exhibit differences in
locomotor behavior (p = 0.12) (Fig. 4e).
Viral-mediated overexpression of Homer1a impairs
auditory fear conditioning
To determine if overexpression of Homer1a in the BLA im-
paired auditory fear conditioning, animals were infused
with AAV-Homer1a and AAV-GFP as described above, and
21 days later, the animals were subjected to auditory fear
conditioning, which consisted of a 30-s, 5-kHz, 75-dB tone
that co-terminated with a 0.75-mA foot shock. Animals
across the two groups appeared to experience the foot
shocks to the same degree as indicated by their response to
the shock (i.e., jumping, flinching, etc.; data not shown).
Three hours following fear conditioning training, retention
of STM was assessed by exposing the rats to two 5-kHz,
75-dB tones within a novel context and subsequently de-
termining the freezing behavior of each rat, to each tone.
The Homer1a animals exhibited significantly reduced
freezing behavior compared to the GFP control group as
revealed by the Mann-Whitney U test (p = 0.03) without
significant differences in freezing per tone within each
group, as revealed by the Friedman test [χ2 = 5.39, p =
0.07] (Fig. 5a). Twenty-four hours following fear condi-
tioning training, LTM was assessed in a similar manner as
STM. The Mann-Whitney U test indicated significantly
higher freezing in the Homer1a group (p = 0.03) compared
to the GFP group without significant differences in freez-
ing per tone within each group, as revealed by the Fried-
man test [χ2 = 5.78, p = 0.67] (GFP = 6, Homer1a = 6)
(Fig. 5b). Considering that all animals reacted strongly to
receiving the foot shock during fear conditioning, the dif-
ferences in freezing between the groups during STM and
LTM, is likely not due to differences in pain perception
but rather due to differences in learning.
In our final set of experiments, we wanted to reproduce
the main effects we observed in the social interaction and
fear conditioning tests when Homer1a was overexpressed
in BLA neurons. However, this time we used AAV viruses
that were designed to express Homer1a with Venus
Fig. 3 Validation that AAV viruses harboring Homer1a or GFP transgenes function as intended. a Viral genome maps for viruses designed to
express Homer1a and GFP. b Representative picture showing GFP infection in the BLA of a naïve animal. c Western blot picture depicting HA
tagged Homer1a transgene expression at ~30 kDa which is absent in the GFP animals. A separate band at ~27 kDa shows endogenous Homer1a
which is present in both Homer1a and GFP virus-infused groups as expected. d A timeline showing the sequence of surgeries and experiments
Banerjee et al. Molecular Autism  (2016) 7:16 Page 8 of 15
fluorescent protein as a c-terminal fusion (H1aV). The
control virus was similarly designed but contained a
point mutation (W24A) in the EVH1 domain of H1aV,
which abolishes the ability of Homer1a to interact with
postsynaptic protein partners (H1aV(W24A)) (Fig. 6a).
The animals were infused with either H1aV or
H1aV(W24A) (Fig. 6b), and twenty-one days later, they
were subjected to social interaction testing and auditory
fear conditioning as described above. During social inter-
action, we observed that H1aV animals spent significantly
less time with a novel test rat compared to H1aV(W24A)
(p = 0.04) as revealed by Mann-Whitney U test while the
mean distance traveled in the social interaction apparatus
was similar between both groups (p = 0.09) (Fig. 6c, d).
Next, the animals were subjected to auditory fear condi-
tioning, which consisted of a 30-s, 5-kHz, 75-dB tone that
co-terminated with a 0.75-mA foot shock. Animals across
the two groups appeared to experience the foot shocks to
the same degree as indicated by their response to the shock
(i.e., jumping, flinching, etc.; data not shown). Twenty-four
hours following fear conditioning, the H1aV animals exhib-
ited significantly reduced freezing compared to animals that
received H1aV(W24A) [p = 0.02; Mann-Whitney U test,
AAV-H1aV(W24A) = 7, AAV-H1aV = 9] (Fig. 6e) without
Fig. 4 Viral mediated overexpression of Homer1a in the BLA impaired social interaction but did not influence innate fear and locomotory
behavior: Animals overexpressing Homer1a exhibit anxiety levels similar to GFP animals in the open field as indicated by (a) a similar number of
center entries and (b) similar center time as compared to GFP animals. c The mean total distance traveled was not different between the groups
(GFP = 8, Homer1a = 9). Animals overexpressing Homer1a exhibit reduced social interaction compared to GFP animals as indicated by (d) reduced
social interaction time without affecting (e) mean distance traveled in the social interaction apparatus. Bars represent the mean ± standard error
of the mean (SEM) (*p < 0.05)
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significant differences in freezing per tone within each
group, as revealed by the Friedman test [χ2 = 1.238,
p = 0.53]. Collectively, these data indicate that over-
expression of Homer1a in the BLA impairs social
interaction and fear conditioning compared to the
H1aV(W24A) control animals.
Discussion
A growing body of literature has identified a range of
autism-like behavioral and synaptic abnormalities in ani-
mals exposed to VPA in utero. This includes a previous
study from our lab where we identified fear learning and
social abnormalities in VPA-exposed animals. In this
study, we identified Homer1a as one of the molecules
that was significantly upregulated in the BLA of VPA-
exposed animals at both the mRNA and protein levels.
We hypothesized that upregulation of Homer1a in the
BLA might be contributing to the behavioral abnormal-
ities observed in VPA-exposed animals. To test our
hypothesis, we used a viral mediated approach to over-
express Homer1a in the BLA of naïve animals. Our
results revealed for the first time that overexpression of
Homer1a within BLA neurons was capable of impairing
auditory fear conditioning and social interaction. These
results are very interesting in part because we were able
to demonstrate a possible causal mechanism underlying
fear conditioning and social interaction abnormalities
observed in an animal model of autism.
Homer is a family of scaffolding proteins found at the
postsynaptic density. Homer1b/c is a longer isoform of
the family which interacts with a number of proteins at
the postsynaptic density. It has an EVH1 domain and a
proline-rich containing motif at the N-terminus, which
binds to various scaffolding and signal transduction
molecules, such as type I mGluR, IP3 receptors (IP3R),
Shank, transient receptor potential canonical (TRPC)
family channels, and dynamin3 [49, 78–81]. The C-
terminus of long isoforms of Homer1 contain a coiled-
coil domain followed by two leucine zipper motifs which
promotes homomeric or heteromeric interactions with
other long isoforms of Homer to form a network and
stabilize the integrity of the postsynaptic density [50].
Homer1a is an immediate early gene (IEG) that codes
for a shorter isoform of Homer1, which lacks the coiled-
coil domain and the ability to interact with other Homer1
molecules. This allows Homer1a to act as a dominant
negative regulator by disrupting the interaction of the long
isoforms and therefore allows Homer1a to reorganize the
postsynaptic density. Homer1a is also involved in intracel-
lular calcium homeostasis, receptor trafficking, gene tran-
scription, signal transduction, and homeostatic synaptic
downscaling [48, 57, 82, 83]. Homer1a also plays a role in
pain plasticity by protecting against chronic inflammatory
pain without affecting the basal pain threshold [76]. Add-
itionally, Homer1a contributes an important role in learn-
ing and memory, and Homer1a knockout animals exhibit
reduced fear memory acquisition as well as reduced short-
term memory [56]. Overexpression of Homer1a inhibits
dendritic spine morphogenesis as well as reduces the size
of PSD95 clusters, N-methyl-D-aspartate (NMDA) recep-
tor clusters and surface levels of α-amino-3-hydroxy-5-
methyl-4-isoxazolepropionic acid (AMPA) receptors [84].
These findings indicate that either a deficit or excess of
Homer1a could be pathological and prevent normal
synaptic functioning.
There is evidence indicating that dysregulation of
Homer1 may be occurring in a sub-population of ASD
patients. For example, a study comprised of a popula-
tion diagnosed with non-syndromic autism identified a
significant number of genes involved in the mGluR5 path-
way including Homer1 [64]. Specifically, single nucleotide
variants (SNV) were identified, which localized to the
EVH1 domain and 3′ untranslated region (UTR) region of
Homer1. A separate postmortem study found reduced
Homer1 protein expression in the frontal cortex of ASD
patients [85]. Moreover, different animal models of autism
have indicated that Homer1 and Homer1a function may
be dysregulated in these models. One study found
Homer1a to have an increased interaction to mGluR5
receptors in the hippocampus, which would disrupt
Fig. 5 Viral-mediated overexpression of Homer1a in the BLA
impaired fear conditioning: Animals infused with either AAV-
Homer1a or AAV-GFP were auditory fear conditioned (AAV-GFP = 6,
AAV-Homer1a = 6). a Auditory fear memory assessed 3 h post fear
conditioning (i.e., STM) demonstrated significantly reduced freezing
in AAV-Homer1a animals. b Auditory fear memory assessed 24 h
post fear conditioning (i.e., LTM) demonstrated significantly reduced
freezing in AAV Homer1a animals compared to GFP animals. Bars
represent the mean ± standard error of the mean (SEM) (*p < 0.05)
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Homer1 scaffolds at the synapse of fragile X mice. In-
creased interaction of Homer1a to mGluR5 in turn en-
hanced mGluR5-dependent long-term depression (LTD)
[38]. Interestingly, a different study found an increased
interaction of mGluR5 to the long isoform of Homer1,
and it was found that this increased interaction also
enhanced mGluR5-dependent LTD in an Angelman
syndrome mouse model [86]. Surprisingly, in the Angel-
man Syndrome study, changes in the coupling of mGluR5
receptors to Homer proteins were opposite to those seen
in fragile X. Nevertheless, these studies underscore
the significant role of Homer1a in the neurobiological
mechanisms leading to ASD.
Our microarray data also revealed other genes such
as Mef2C, gfap, grxcr1, and sgk1, which were dysregu-
lated in VPA-exposed animals (complete gene list in
Additional file 1.). Homer1a’s previously established
role in learning and its association with human ASD
made it an attractive candidate to pursue in the
present study. However, it will be interesting to inves-
tigate the role of these other genes in the future to
determine how they may contribute to the aberrant
behavioral and synaptic abnormalities seen in the
VPA-exposed animals. We propose that dysregulation
of many genes, which include Homer1a, gives rise to
the ASD phenotype seen in VPA-exposed animals,
and it would be unlikely that Homer1a alone is solely
impairing fear conditioning or social interaction. Our
experimental data clearly indicate that Homer1a is
consistently upregulated in neurons from the BLA of
VPA-exposed animals and that when we overexpress
Homer1a within the BLA utilizing viral mediated gene
delivery, we observe impairments in fear conditioning
and social interaction behavior compared to the con-
trol groups. However, an important caveat of these
viral-mediated gene delivery experiments is that they
do not provide the ability to precisely adjust Homer1a
levels to mirror what is occurring exactly within
VPA-exposed animals.
It is well known that the amygdala can modulate social
behavior and is a hub for brain networks that support
social life. For example, bilateral lesions of the amygdala
in monkeys can reduce social behavior and increase
social phobia [77] and neonatal amygdala lesions sup-
pressed social interactions in adult rats [87]. A recent
study demonstrated a critical role for BLA neurons that
project to the hippocampus in bi-directionally modulat-
ing social behavior. This study demonstrated that over
Fig. 6 Viral-mediated overexpression of AAV-H1aV in the BLA impaired social interaction and fear conditioning: Animals were infused with either
AAV-H1aV designed to overexpress Homer1a or AAV-H1aV(W24A) designed to expressed a mutant form of Homer1a, which served as a control.
a Viral genome maps depicted for AAV-H1aV and AAV-H1aV(W24A). b Representative picture depicting AAV-H1aV viral transduction in the BLA of
naïve animals. AAV-H1aV animals exhibit reduced social interaction compared to AAV-H1aV(W24A) as indicated by (c) reduced social interaction
time without affecting (d) mean distance traveled in the social interaction apparatus (AAV-H1aV(W24A) = 7, AAV-H1aV = 8). e Animals expressing
AAV-H1aV and AAV-H1aV(W24A) were subjected to auditory fear conditioning, and 24 h later, they were examined for LTM. AAV-H1aV animals
exhibited significantly reduced freezing compared to AAV-H1aV(W24A) animals
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activation of these BLA projection neurons could reduce
social interaction [88]. However, the molecular mecha-
nisms in the amygdala that influence social behavior still
remain largely unknown. For the first time, we demon-
strate that overexpression of Homer1a in BLA neurons
impairs social interaction in naïve animals.
Valproic acid is a histone deacetylase (HDAC) inhibitor
and is prescribed for the treatment of epilepsy [89–91].
The mechanism by which VPA acts at the molecular level
is currently not fully understood. Pups exposed to VPA in
utero exhibited increased total brain, brain-derived neuro-
trophic factor (BDNF) expression and abnormal develop-
ment of serotonergic neurons in the dorsal raphe nucleus
[92, 93]. Various biochemical studies indicate that VPA
can suppress neuronal activity by blocking sodium and
calcium channels and enhance the functioning of the
inhibitory neurotransmitter, gamma-aminobutyric acid
(GABA), in the brain [94, 95]. Further, in an attempt to
understand the mechanism of VPA-induced toxicity,
several studies found dysregulated gene expression related
to organ morphogenesis and neural tube defects [96–100],
and these affects have been attributed to VPA’s ability to
inhibit histone deacetylase [101–103]. Since HDAC plays
an important role in regulating transcription during fetal
development [45, 104, 105], it is possible that VPA may
induce abnormal gene expression during embryogenesis,
causing autism-like behavioral impairments. For example,
a recent rodent study demonstrated that inhibition of
HDAC in utero is sufficient to cause autism-like pheno-
types including sociability deficits in exposed offspring
[106]. Further research needs to be conducted to under-
stand how exposure to VPA in utero is causing overex-
pression of Homer1a.
Conclusions
ASD is a heterogeneous disorder with a complex under-
lying molecular mechanism. It is very likely that the be-
havioral impairments observed in an ASD individual are
caused by multiple synaptic deficits. However, Homer1a
contributes a significant role in synaptic plasticity within
a larger glutamatergic system—dysregulation of which
has been clearly implicated in ASD [64, 107–109]. Our
findings indicate that overexpression of Homer1a in the
BLA can induce autism-like symptoms which provides
novel and interesting information for the ASD research
community and can be further investigated for their role
as a possible therapeutic intervention through genetic or
pharmacological manipulations.
Additional files
Additional file 1: Table comparing parametric and non-parametric
statistical outcome for selected behavioral experiments. For
behavioral experiments with sample sizes of n < 10 per group, statistical
analyses were performed using both parametric and non-parametric
statistical analysis to eliminate chances of normality assumption violation.
(XLSX 15 kb)
Additional file 2: Table of microarray data from VPA exposed rats
compared to saline exposed control animals. Gene lists were created
based on the criteria that the gene must exhibit an average fold
difference of 1.5 fold or greater in pair wise comparisons between VPA
and saline amygdala samples with a t-test p-value of p < 0.05. Microarray
data listed, with Probe ID, Gene symbol, Gene name, etc. (XLSX 16 kb)
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